Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: Inhibition by adenosine A(2A) receptor agonists and crucial role of autocrine activation by leukotriene B4

Molecular Pharmacology

Volumn 56, Issue 5, 1999, Pages 1055-1062

  Surette, Marc E ^b   Krump, Eric ^b   Picard, Serge ^b   Borgeat, Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 (3 CARBOXYBENZOYL) 2 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]HYDROCINNAMIC ACID; ADENOSINE; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE DEAMINASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIUM; LEUKOTRIENE; LEUKOTRIENE B4;

ARTICLE; AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL STIMULATION; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0032704462     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.5.1055     Document Type: Article

References (41)

1. Barr RM, Wong E, Mallet AI, Olins LA and Greaves MW (1984) The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin. Prostaglandins 28:57-65.
2. Borgeat P, Fruteau de Laclos B and Maclouf J (1983) New concepts in the modulation of leukotriene synthesis. Biochem Pharmacol 32:381-387.
3. Borgeat P and Naccache PH (1990) Biosynthesis and biological activity of leukotriene B4. Clin Biochem 23:459-468.
4. Borgeat P, Picard S, Vallerand P, Bourgoin S, Odeimat A, Sirois P and Poubelle PE (1990) Automated on-line extraction and profiling of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Methods Enzymol 187:98-116.
5. Boyum A ( 1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 21:77-89.
6. Chasteen ND, Grady JK, Skorey KI, Neden KJ, Riendeau D and Percival MD (1993) Characterization of the non-heme iron center of human 5-lipoxygenase by electron paramagnetic resonance, fluorescence, and ultraviolet-visible spectroscopy: Redox cycling between ferrous and ferric states. Biochemistry 32:9763-9771.
7. Clancy RM, Dahinden CA and Hugli TE (1983) Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci USA 80:7200-7204.
8. Cronstein BN (1994) Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13.
9. Cronstein BN (1995) The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism. Br J Rheumatol 2:30-32.
10. Cronstein BN, Kramer SB, Weissmann G and Hirschhorn R (1983) Adenosine: A physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158:1160-1177.
11. Dahinden CA, Zingg J, Maly FE and de Weck AL (1988) Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5a and FMLP as second signals. J Exp Med 167:1281-1295.
12. Faucher N and Naccache PH (1987) Relationship between pH, sodium, and shape changes in chemotactic-factor-stimulated human neutrophils. J Cell Physiol 132: 483-491.
13. Fonteh AN, Winkler JD, Torphy TJ, Heravi J, Undem BJ and Chilton FH (1993) Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil. J Immunol 151:339-350.
14. Ghai G, Francis JE, Williams M, Dotson RA, Hopkins MF, Cote DT, Goodman FR and Zimmerman MB (1987) Pharmacological characterization of CGS 15943A: A novel nonxanthine adenosine antagonist. J Pharmacol Exp Ther 242:784-790.
15. Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E and Kuehl FA Jr (1983) Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 80:4349-4353.
16. Jackson WT, Boyd RJ, Froelich LL, Mallett BE and Gapinski DM (1992) Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982. J Pharmacol Exp Ther 283:1009-1014.
17. Krump E and Borgeat P (1994) Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: Effects of granulocyte-macrophage colony-stimulating factor. Biochim Biophys Acta 1213:135-139.
18. Krump E, Boudreault S, Picard S, Austin M, Surette ME, Plante H, Flamand N, Vallée MJ, Gilbert C and Borgeat P (1999) Adenosine, a potent natural suppressor of leukotriene biosynthesis in human neutrophils. Am J Respir Crit Care Med, in press.
19. Krump E, Lemay G and Borgeat P (1996) Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo. Br J Pharmacol 117:1639-1644.
20. Krump E, Picard S, Mancini J and Borgeat P (1997) Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. J Exp Med 186:1401-1406.
21. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
22. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA and Austen KF (1984) Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74:1922-1933.
23. Lepley RA, Muakardin DT and Fitzpatrick FA (1996) Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J Biol Chem 271:6179-6184.
24. Lundy SR, Dowling RL, Stevens TM, Kerr JS, Mackin WM and Gans KR (1990) Kinetics of phospholipase A2, arachidonic acid, and eicosanoid appearance in mouse zymosan peritonitis. J Immunol 144:2671-2677.
25. Maclouf J, Fitzpatrick FA and Murphy RC (1989) Transcellular biosynthesis of eicosanoids. Pharmacol Res 21:1-7.
26. McColl SR, Krump E, Naccache PH, Caon AC and Borgeat P (1989) Activation of the human neutrophil 5-lipoxygenase by exogenous arachidonic acid: Involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins. Br J Pharmacol 97:1265-1273.
27. McDonald PP, McColl SR, Braquet P and Borgeat P (1994) Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils. Br J Pharmacol 111:852-860.
28. Naccache PH, McColl SR, Caon AC and Borgeat P (1989) Arachidonic acid-induced mobilization of calcium in human neutrophils: Evidence for a multicomponent mechanism of action. Br J Pharmacol 97:461-468.
29. Nevalainen TJ (1993) Serum phospholipases A2 in inflammatory diseases. Clin Chem 39:2453-2459.
30. Newby AC, Holmquist CA, Illingworth J and Pearson JD (1983) The control of adenosine concentration in polymorphonuclear leukocytes, cultured heart cells and isolated perfused heart from the rat. Biochem J 214:317-323.
31. Palmantier R and Borgeat P (1991) Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists. Br J Pharmacol 103:1909-1916.
32. Pouliot M, McDonald PP, Krump E, Mancini JA, McColl SR, Weech PK and Borgeat P (1996) Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem 238:250-258.
33. Powell WS, Rokach J, Khanapure SP, Manna S, Hashefi M, Gravel S, Macleod RJ, Falck JR and Bhatt RK (1996) Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels. J Pharmacol Exp Ther 276:728-736.
34. Serhan CN and Sheppard KA (1990) Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest 85:772-780.
35. Showell HJ, Pettipher ER, Cheng JB, Breslow R, Conklyn MJ, Farrell CA, Hingorani GP, Salter ED, Hackman BC and Wimberly DJ (1995) The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. J Pharmacol Exp Ther 273:176-184.
36. Skorey KI and Grosser MJ (1998) Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations. Biochemistry 37:8027-8034.
37. Smith RJ, Sam LM, Justen JM, Leach KL and Epps DE (1987) Human polymorphonuclear neutrophil activation with arachidonic acid. Br J Pharmacol 91:641-649.
38. Stenson WF and Parker CW (1979) Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. J Clin Invest 64:1457-1465.
39. Surette ME, Dallaire N, Jean N, Picard S and Borgeat P (1998) Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils. FASEB J 12:1521-1531.
40. Woods JW, Evans JF, Ethier D, Scott S, Vickers PJ, Hearn L, Heibein JA, Charleson S and Singer II (1993) 5-lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 178:1935-1946.
41. Yokomizo T, Izumi T, Chang K, Takuwa Y and Shimizu T (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature (Lond) 387:6204-620.